Tags |
|
|
Links |
|
|
Main Subject - Management to the Vision-Contribution and the Role of Compliance
As a manager our role is to:
1. Establish the vision, or our contribution to the vision.
2. Establish the plan and forecast for our management contr
1. Establish the vision, or our contribution to the vision.
2. Establish the plan and forecast for our management contr
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ibution, be it $1million or $1billion.
3. Gain endorsement of the plan and forecast, by the vision holders.
4. Manage the plan and reality to the vi
3. Gain endorsement of the plan and forecast, by the vision holders.
4. Manage the plan and reality to the vi
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ion-contribution.
This is very simple on paper.
Assuming we have achieved the first three, let’s focus on the fourth as it is vitally important.
Fi
This is very simple on paper.
Assuming we have achieved the first three, let’s focus on the fourth as it is vitally important.
Fi
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
rstly, too many managers make a subtle twist here and manage the deliverables to the plan forgetting that the vision is the ultimate goal! To tweak t
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
e plan as we go, means we may readily exceed our contribution to the vision within the time frame. This is a wonderful over achievement, there to for
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
the having, if our eyes, ears and hearts are open to the possibility!
My client had a plan to deliver sales of budget for the year. Nearing the end
My client had a plan to deliver sales of budget for the year. Nearing the end
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
of Q3 they found they had exceeded budget substantially and could set a new target 25% over the previous budget. All it required to be done was to co
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ntinue to sell at the same levels. There had been no product withdrawals by the competition, no category killers by their own company, just an extrao
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
dinary and consistent performance.
Her focus was on the vision not the plan, the plan would have enabled her to relax in Q4 and focus on a killer Q1.
Her focus was on the vision not the plan, the plan would have enabled her to relax in Q4 and focus on a killer Q1.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
The vision meant she could change the contribution now.
Secondly, compliance is the ability to have others deliver the vision. Our client’s staff
Secondly, compliance is the ability to have others deliver the vision. Our client’s staff
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
an be joined into the vision, be left out but still be expected to deliver it.
IT consultants have delivered huge IT project to enable technological
IT consultants have delivered huge IT project to enable technological
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
advances in work processes for years. The average to poor ROI projects may have great IT but do not readily fit the culture or the creative energy of
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
the company.
Again a subtle but profound twist occurs. We focus on the technology to deliver the results and serve its requirements, rather than fin
Again a subtle but profound twist occurs. We focus on the technology to deliver the results and serve its requirements, rather than fin
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ding the model of delivery and have the technology serve it!
The business model is established and the technology serves it, and example.
A consulta
The business model is established and the technology serves it, and example.
A consulta
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
t to QANTAS found they had over 100 interfaces for the IT group to maintain and support – an enormous technical feat for their staff numbers! The iss
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ue arose as IT was too slow in partnering with the business units in making the decisions about the technology to support their initiatives.
He simpl
He simpl
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
fied the process of interaction to a one page intranet form and 24 hours for low budget projects; and, one page intranet form and rapid interaction fo
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
r more complex projects. The businesses found it easy to engage IT and IT added value by delivering better technical help and support for their initi
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
tives.
As a result no new interfaces were introduced, and, many were retired or relegated to less essential operational areas. Millions of dollars a
As a result no new interfaces were introduced, and, many were retired or relegated to less essential operational areas. Millions of dollars a
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
nd man hours were also saved.
Is your management two dimensional and falling over for you, or three dimensional, challenging, interesting and dynamic
Is your management two dimensional and falling over for you, or three dimensional, challenging, interesting and dynamic
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/24243/mainsubjects-Management-to-the-VisionContribution-and-the-Role-of-Compliance.html">Management to the Vision-Contribution and the Role of Compliance</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/24243/mainsubjects-Management-to-the-VisionContribution-and-the-Role-of-Compliance.html]Management to the Vision-Contribution and the Role of Compliance[/url]
Related Articles:
Medical Billing - GE0 Record Fields 9 Through 14
Advertise with Little or No Money
Conflicts With Your Boss Are Inevitable, But Can Be Healthy
Bookmark it:
|